7 Stocks to Get Your Heart Racing!

NASDAQ: CPRX | Catalyst Pharmaceuticals, Inc. News, Ratings, and Charts

CPRX – Catalyst Pharma is trading 51% under its fair value target…and that is the most boring stock on this list. Read on to discover the full list of 7 with up to 155% upside.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

The market has been volatile and unkind to most smaller, riskier stocks. But if you are like me, there are only so many conservative large cap income stocks you can load up in your portfolio. At some point you need to get your heart racing and take a calculated risk.

If that sounds like you too, then these 7 stocks under $10 should be right up your alley.

The tamest of these stocks is Catalyst Pharma (CPRX) that has 51% upside to attain its fair value target set by Wall Street analysts. And sitting on top of the list with 155% upside is DURECT Corp (DRRX).

Let’s pull back a notch to appreciate the in-depth research process I went through to narrow down to these stocks.

  • 8,000+ US based stocks to start with.
  • 1,435 with POWR Rating of A or B. As you likely know by now, this is our proprietary rating system that is built on top of 4 different scores of a stocks attractiveness. When rolled together it points to stocks experiencing the most healthy momentum at this time and thus likely to stay on the rise.
  • 107 stocks with a price of $10 or less. Like I said it was time to get some excitement happening in our portfolios. Sure these are more speculative stocks, but I mitigate that risk by the employing other criteria to increase the odds of success. POWR Ratings is one such factor. But also the next 2 parameters are vital health checks on these stocks.
  • 83 stocks with a price target placed on them by Wall Street analysts. Meaning that 24 of them were not followed by the street. Without that important fact checking process in place, I’d rather pass on those stocks.
  • 44 stocks with consensus earnings estimates flat to higher for this year and next. This is a important health check coming out of Q2 earnings season. That’s because if estimates were heading lower…likely that negative trend would continue with much greater odds of that stock falling further in price.
  • 7 Stocks with 50% or more upside to fair value targets set by Wall Street analysts.

When you add it altogether we are talking about 7 stocks that blend healthy earnings growth + momentum + extreme value. Check them out below.

 

Company Ticker Price Target Upside % Market Cap ($mil)
   Durect Corp DRRX $1.37 $3.50 155.47% $263
   Lipocine Inc LPCN $2.40 $5.67 136.25% $60
   Compugen Ltd CGEN $3.91 $8.50 117.39% $201
   Asanko Gold Inc AKG $0.88 $1.60 81.82% $199
   Avid Bioservics CDMO $6.61 $10.50 58.85% $371
   Volitionrx Ltd VNRX $4.10 $6.25 52.44% $168
   Catalyst Pharma CPRX $6.18 $9.33 50.97% $636

What to Do Next?

I would recommend clicking on the links for the stocks that have the most appeal to you. That will take you to their respective quote pages on StockNews.com where you can find a more in-depth understanding of the stock.

I am referring to the full display of the POWR Ratings for the stock where we break it down into  4 components to appreciate the full attractiveness of the investment. a stock. That includes its Buy & Hold Grade, Trading Grade, Industry Rank and Peer Grade. Just click the ticker for each stock to discover that information and more.

One last thing…

Every day I share a limited number of top stocks through articles just like this one. However, you are cutting yourself short from all the resources of the POWR Ratings system that will help you find the best stocks to buy at any time. Not just speculative stocks like these, but large caps, high dividend, value, growth and momentum stocks.

Ratings are updated every day. And that includes updates on the stocks to sell before they harm your portfolio.

But they are only available to POWR Ratings Premium members. Gladly we have a 30 day free trial which is the best way to get started. Just click the link below to learn more and get started.

30 Day Free Trial to POWR Ratings Premium

 


Catalyst Pharmaceuticals, Inc. (CPRX - Get Rating) shares rose $0.02 (+0.32%) in after-hours trading Wednesday. Year-to-date, Catalyst Pharmaceuticals, Inc. (CPRX - Get Rating) has gained 226.56%, versus a 18.10% rise in the benchmark S&P 500 index during the same period.

 


About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CPRXGet RatingGet RatingGet Rating
AKGGet RatingGet RatingGet Rating
CDMOGet RatingGet RatingGet Rating
CGENGet RatingGet RatingGet Rating
DRRXGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NASDAQ: BGCP | BGC Partners, Inc. -  News, Ratings, and Charts

7 Extreme Yield, Extreme Value Stocks

BGCP delivers 9.77% dividend yield and 57% upside to fair value targets. And that is only 1 of the 7 stellar stocks shared below.
: .INX | S&P 500 Index News, Ratings, and Charts

The Good & Bad News of the US-China Trade War

Thanks to the fast-changing soap opera that is the US/China Trade war stocks have spent much of the last year going nowhere fast. Continue reading to find out the good and bad news about the trade war.
: ctst | CannTrust Holdings Inc. Common Shares News, Ratings, and Charts

CannTrust (CTST) Loses its License, What Happens Next?

Just as we thought we were coming to a conclusion in terms of the CannTrust (CTST) scandal, things took another turn.
NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Replay: 9/17 Reitmeister's Strategy Session Webinar

9/17 marked the launch of the Reitmeister Strategy Session webinar series. See the topics covered below and with link to on-demand replay video.
NASDAQ: PENN | Penn National Gaming, Inc. News, Ratings, and Charts

Time to Unwrap the Stock of the Week

Time to place your chips on Penn National Gaming. 40% EPS growth + 36% upside to fair value.

Read More Stories


More Catalyst Pharmaceuticals, Inc. (CPRX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CPRX News
Page generated in 1.381 seconds.